 |
 |
 |
| 24小時(shí)熱門版塊排行榜 |
- >論壇更新日志 (1708)
- >考研 (187)
- >導(dǎo)師招生 (129)
- >蟲(chóng)友互識(shí) (77)
- >考博 (27)
- >文獻(xiàn)求助 (26)
- >論文投稿 (24)
- >休閑灌水 (18)
- >博后之家 (17)
- >碩博家園 (16)
- >找工作 (15)
- >文獻(xiàn)求助完結(jié)子版 (14)
- >基金申請(qǐng) (12)
- >論文道賀祈福 (8)
- >教師之家 (8)
- >職場(chǎng)人生 (5)
 |
 |
 |
||
 |
 |
 |
 |
 |
| 1 | 1/1 | 返回列表 |
| 查看: 204 | 回復(fù): 0 | |||
biomill8358無(wú)蟲(chóng) (小有名氣)
|
[交流]
【分享】重編程人類外周血細(xì)胞誘導(dǎo)多功能干細(xì)胞
|
|
Reprogramming of Human Peripheral Blood Cellsto Induced PluripotentStem Cells 重編程人類外周血細(xì)胞誘導(dǎo)多功能干細(xì)胞 Judith Staerk,1 MeeladM. Dawlaty,1 Qing Gao,1 1The Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA Cell Stem Cell 7, July 2, 2010 Embryonic stem cells are pluripotentcells derived from the inner cell mass of the developing embryo that have the capacity to differentiate into every cell type of the adult (Evans and Kaufman, 1981; Martin,1981; Martin and Evans, 1975; Thomsonetal., 1998). The generation of patientspecificpluripotentcells is therefore an important goal of regenerative medicine.Amajor step to achieve this was the recent discovery that ectopic expression of defined transcription factors induces pluripotencyin somatic cells (Lowry et al., 2008; Park et al., 2008b; Takahashi et al., 2007; Yu et al., 2007). Until now, the most common source from which to derive human iPSCshas been skin fibroblasts (Lowry et al., 2008; Park et al.,2008a, 2008b; Takahashi et al., 2007; Yu et al., 2009). However, the requirement for skin biopsies and the need to expand fibroblast cells for several passages in vitro represent a hurdle that must be overcome to make iPSCtechnology broadly applicable. Peripheral blood can be utilized as an easily accessible source of patient tissue for reprogramming. Here we derived iPSCsfrom frozen human peripheral blood samples. Some of the iPSCshad rearrangements of the T cell receptor (TCR), indicating that T cells can be reprogrammed to pluripotency. 1.目前，誘導(dǎo)人類iPSCs的最常見(jiàn)的來(lái)源是皮膚成纖維細(xì)胞。但是，對(duì)皮膚進(jìn)行組織切片檢查需要在體外擴(kuò)增成纖維細(xì)胞，而體外擴(kuò)增成纖維細(xì)胞成為阻礙iPSCs技術(shù)的廣泛應(yīng)用的困難之一。 2.外周血很容易獲得。作者通過(guò)凍存的人類外周血樣品誘導(dǎo)iPSCs。 更多資料請(qǐng)查看www.bioknow.cn |
回復(fù)此樓» 猜你喜歡
085601 329分調(diào)劑
已經(jīng)有3人回復(fù)
-
本2一志愿C9-333分，材料科學(xué)與工程，求調(diào)劑
已經(jīng)有3人回復(fù)
-
一志愿大連理工大學(xué)材料求調(diào)劑
已經(jīng)有5人回復(fù)
-
材料與化工調(diào)劑一志愿大連海事085600，349
已經(jīng)有6人回復(fù)
-
一志愿中海洋320化學(xué)工程與技術(shù)學(xué)碩求調(diào)劑
已經(jīng)有4人回復(fù)
-
材料科學(xué)與工程調(diào)劑
已經(jīng)有11人回復(fù)
-
311求調(diào)劑一志愿合肥工業(yè)大學(xué)
已經(jīng)有4人回復(fù)
-
一志愿食品科學(xué)與工程083200求調(diào)劑
已經(jīng)有4人回復(fù)
-
材料科學(xué)與工程求調(diào)劑
已經(jīng)有10人回復(fù)
-
一志愿北化085600材料專碩275|有文章專利｜求調(diào)劑
已經(jīng)有11人回復(fù)
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 biomill8358 的主題更新
| 1 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 求調(diào)劑 +3 | 圖鑒212 2026-03-30 | 3/150 |
|
|---|---|---|---|---|
|
|
[考研] 本科211總分289，08工學(xué)真心求調(diào)劑 +3 | utopiaE 2026-03-30 | 3/150 |
|
|
|
[考研] 071010 323 分求調(diào)劑 +3 | Baekzhy 2026-03-27 | 3/150 |
|
|
|
[考研] 085701求調(diào)劑初試286分 +5 | secret0328 2026-03-28 | 5/250 |
|
|
|
[考研] 環(huán)境科學(xué)與工程334分求調(diào)劑 +6 | 王一一依依 2026-03-30 | 8/400 |
|
|
|
[考研] 0856求調(diào)劑 +8 | 楒桉 2026-03-28 | 8/400 |
|
|
|
[考研] 求調(diào)劑 +10 | 張zz111 2026-03-27 | 11/550 |
|
|
[考研] 311求調(diào)劑 +6 | 冬十三 2026-03-24 | 6/300 |
|
|
|
[考研] 考研調(diào)劑 +7 | 小蠟新筆 2026-03-29 | 7/350 |
|
|
|
[考研] 327求調(diào)劑 +6 | 汲亦昊 2026-03-29 | 6/300 |
|
|
|
[考研] 數(shù)一英一271專碩（085401）求調(diào)劑，可跨 +7 | 前行必有光 2026-03-28 | 8/400 |
|
|
|
[考研] 315求調(diào)劑 +4 | akie... 2026-03-28 | 5/250 |
|
|
|
[考研]
 一志愿 西北大學(xué) 總分282 英語(yǔ)一62 求調(diào)劑
+7
|
18419759900 2026-03-25 | 8/400 |
|
|
|
[考研] 303求調(diào)劑 +6 | 藍(lán)山月 2026-03-25 | 6/300 |
|
|
|
[考研] 334分 一志愿武理-080500 材料求調(diào)劑 +4 | 李李不服輸 2026-03-25 | 4/200 |
|
|
|
[考研] 材料與化工304求B區(qū)調(diào)劑 +3 | 邱gl 2026-03-25 | 3/150 |
|
|
|
[考研] 285求調(diào)劑 +3 | AZMK 2026-03-24 | 3/150 |
|
|
|
[考研] 293求調(diào)劑 +7 | 加一一九 2026-03-24 | 7/350 |
|
|
|
[考研] 086003食品工程求調(diào)劑 +6 | 淼淼111 2026-03-24 | 6/300 |
|
|
|
[考研] 調(diào)劑 +4 | 13853210211 2026-03-24 | 4/200 |
|